Trade Mark Journal No.2021/053 31 December 2021

WO0000001630031 (5,42)

Office of origin: United States of America

Date of International Registration:2 July 2021
Date of designation in the UK: 2 July 2021
Image for mark 1630031 SPOROS BIOVENTURES

International priority date claimed: 4 January 2021 (United States of America) (90447021)
Class 5
Pharmaceutical preparations for the prevention of cancer and immune diseases.
Class 42
Research and development in the field of pharmaceutical preparations for the prevention of cancer and immune diseases.

Sporos Bioventures LLC

Representative: Douglas R. Wolf, 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA